Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.
The library features a range of promising modulators, each detailed with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Plus, each compound is presented with its ideal docking poses, affinity scores, and activity scores, ensuring a thorough insight.
Our high-tech, dedicated method is applied to construct targeted libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our strategy employs molecular simulations to explore an extensive range of proteins, capturing their dynamics both individually and within complexes with other proteins. Through ensemble virtual screening, we address proteins' conformational mobility, uncovering key binding sites at both functional regions and remote allosteric locations. This comprehensive investigation ensures a thorough assessment of all potential mechanisms of action, with the goal of discovering innovative therapeutic targets and lead molecules across across diverse biological functions.
Our library stands out due to several important features:
partner
Reaxense
upacc
P35243
UPID:
RECO_HUMAN
Alternative names:
Cancer-associated retinopathy protein
Alternative UPACC:
P35243; Q53XL0
Background:
Recoverin, also known as Cancer-associated retinopathy protein, plays a pivotal role in the visual system. It acts as a calcium sensor, regulating phototransduction in cone and rod photoreceptor cells. By modulating light sensitivity and prolonging RHO/rhodopsin activation, Recoverin enhances vision in low light conditions and plays a crucial role in scotopic vision, facilitating the detection of change and motion in bright light.
Therapeutic significance:
Understanding the role of Recoverin could open doors to potential therapeutic strategies.